Singulair

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:approves gptkb:1998
gptkb:FDA
gptkbp:available_on generic version
gptkbp:brand gptkb:Singulair
Montelukast Sodium
gptkbp:class leukotriene receptor antagonist
gptkbp:clinical_trial Phase III
gptkbp:condition seasonal allergies
chronic rhinosinusitis
exercise-induced bronchoconstriction
allergic asthma
perennial allergies
gptkbp:contraindication hypersensitivity to montelukast
gptkbp:dosage_form gptkb:tablet
granules
chewable tablet
gptkbp:form gptkb:tablet
granules
chewable tablet
https://www.w3.org/2000/01/rdf-schema#label Singulair
gptkbp:ingredients montelukast
gptkbp:interacts_with gptkb:phenobarbital
gptkb:carbamazepine
gptkb:rifampin
gptkb:warfarin
gptkb:prednisone
gptkbp:invention gptkb:2012
gptkbp:manufacturer gptkb:Merck_&_Co.
gptkbp:marketed_as gptkb:Australia
gptkb:Canada
gptkb:India
gptkb:United_Kingdom
gptkb:United_States
gptkbp:packaging gptkb:bottle
blister pack
gptkbp:requires prescription only
gptkbp:route_of_administration oral
gptkbp:side_effect dizziness
fatigue
headache
nausea
sleep disturbances
stomach pain
liver enzyme elevation
skin rash
mood changes
increased bleeding tendency
gptkbp:storage room temperature
dry place
gptkbp:used_for gptkb:asthma
allergic rhinitis
gptkbp:bfsParent gptkb:Merck_Sharp_&_Dohme_Corp.
gptkb:Merck_&_Co.,_Inc.
gptkbp:bfsLayer 6